Open AccessP667: LONG‐TERM EFFICACY OF ACALABRUTINIB‐BASED REGIMENS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND HIGHER‐RISK GENOMIC FEATURES: POOLED ANALYSIS OF CLINICAL TRIAL DATA
Author(s) -
Davids M.,
Sharman J.,
Ghia P.,
Woyach J.,
Jurczak W.,
Siddiqi T.,
Miranda P.,
Shahkarami M.,
Yu T.,
Emeribe U.,
Byrd J.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845552.95839.3f
Subject(s) - ighv@ , medicine , chronic lymphocytic leukemia , chemoimmunotherapy , oncology , obinutuzumab , population , venetoclax , cohort , fludarabine , progression free survival , leukemia , chemotherapy , cyclophosphamide , environmental health